The paradox in pneumococcal serotypes: Highly invasive does not mean highly lethal

European Respiratory Journal

Volumn 36, Issue 4, 2010, Pages 712-713

  Pletz, M W ^a   Welte, T ^a   Klugman, K P ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

BACTEREMIA; BACTERIAL STRAIN; EDITORIAL; HUMAN; IMMUNOCOMPROMISED PATIENT; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

HUMANS; PNEUMOCOCCAL VACCINES; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; POLYSACCHARIDES; REGRESSION ANALYSIS; RISK; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 77957847500     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00041210     Document Type: Editorial

References (14)

1. Garcia-Vidal C, Ardanuy C, Tubau F, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010; 65: 77-81.
2. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-237.
3. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-776.
4. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187: 1424-1432. (Pubitemid 36549688)
5. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83-93.
6. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681-689.
7. Imohl M, Reinert RR, van der Linden M. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age. Clin Microbiol Infect 2009; 15: 1008-1012.
8. Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med 2009; 361: 2582-2583.
9. Luján M, Gallego M, Belmonte Y, et al. Influence of pneumococcal serotype group on outcome in adults with bacteremic pneumonia. Eur Respir J 2010; [Epub ahead of print DOI: 10.1183/09031936.00176309].
10. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6: e1000081.
11. Vallès X, Roca A, Lozano F, et al. Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J 2010; 36: 856-863.
12. Kronborg G, Weis N, Madsen HO, et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis 2002; 185: 1517-1520. (Pubitemid 34507977)
13. Steenhoff AP, Wood SM, Rutstein RM, et al. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Pediatr Infect Dis J 2008; 27: 886-891.
14. Alanee SR, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45: 46-51.